About Torl Bio
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $96,000,000 · Series-B
fundraisingfox.com
- Capital Raise
Raised $158,000,000 · Series-B
Backed by Deep Track Capital
- Capital Raise
Raised $158,000,000 · Series-B
Backed by Goldman Sachs Asset Management
Investors & Backers
Funding History
Round backers: Deep Track Capital
Round backers: Goldman Sachs Asset Management
Founders & Leadership
Aran Maree
Chief Executive Officer
Christine Loggins
Chief Operating Officer
David Licata
Founder
Dennis Slamon
Founder
Steve Ritland
Chief Scientific Officer
Vince Ruiz
General Counsel
Press Coverage & Sources
fundraisingfox.com/companies/torl-bio
prnewswire.com/news-releases/torl-biotherapeutics-announces-158-million-oversubscribed-series-b-2-financing-to-advance-the-clinical-development-of-its-novel-antibody-drug-conjugate-adc-oncology-pipeline-302112553.html
benzinga.com/pressreleases/23/04/n31795528/torl-biotherapeutics-launches-with-158-million-series-b-financing-to-advance-development-of-novel-
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Commit Biologics
commitbio.com
Human Biome
human-biome.com
MedInTech
medintech.co.kr
Ace Padel
acepadel.com
Mentix
mentix.world